There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on TMX Group (TMXXF) and Metlife (MET) with bullish sentiments.
TMX Group (TMXXF)
In a report released yesterday, Jeremy Campbell from Barclays maintained a Buy rating on TMX Group, with a price target of C$128.00. The company’s shares closed last Monday at $87.93, equals to its 52-week high of $87.93.
According to TipRanks.com, Campbell is a 3-star analyst with an average return of 1.9% and a 57.1% success rate. Campbell covers the Financial sector, focusing on stocks such as Virtus Investment Partners, Intercontinental Exchange, and Apollo Global Management.
Currently, the analyst consensus on TMX Group is a Moderate Buy with an average price target of $95.42, an 8.5% upside from current levels. In a report issued on October 29, Scotiabank also reiterated a Buy rating on the stock with a C$133.00 price target.
See today’s analyst top recommended stocks >>
Metlife (MET)
In a report released yesterday, Jay Gelb from Barclays maintained a Buy rating on Metlife, with a price target of $59.00. The company’s shares closed last Monday at $49.32, close to its 52-week high of $51.16.
According to TipRanks.com, Gelb is a 5-star analyst with an average return of 7.5% and a 67.3% success rate. Gelb covers the Financial sector, focusing on stocks such as American International Group, Renaissancere Holdings, and Berkshire Hathaway A.
Metlife has an analyst consensus of Moderate Buy, with a price target consensus of $56.00, implying a 13.6% upside from current levels. In a report issued on October 31, Wells Fargo also assigned a Buy rating to the stock with a $57.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
